title: Aromatic amino acids are utilized and protein synthesis is stimulated during amino acid infusion in the ovine fetus.
abstract: The purpose of this study was to determine whether the ovine fetus is capable of increased disposal of an amino acid load; if so, would it respond by increased protein synthesis, amino acid catabolism or both? A further purpose of the study was to determine whether the pathways of aromatic amino acid catabolism are functional in the fetus. Late gestation ovine fetuses of well-nourished ewes received an infusion of Aminosyn PF alone (APF), and Aminosyn PF + glycyl-L-tyrosine (APF+GT) at rates estimated to double the intake of these amino acids. The initial study, using APF, was performed at 126 +/- 1.4 d; the APF+GT study was performed at 132 +/- 1.7 d (term = 150 d). Phenylalanine and tyrosine kinetics were determined using both stable and radioactive isotopes. Plasma concentrations of most amino acids, but not tyrosine, increased during both studies; tyrosine concentration increased only during the APF+GT study. Phenylalanine rate of appearance and phenylalanine hydroxylation increased during both studies. Tyrosine rate of appearance increased only during the APF+GT study; tyrosine oxidation did not increase during either study. Fetal protein synthesis increased significantly during both studies, producing a significant increase in fetal protein accretion. Fetal proteolysis was unchanged in response to either amino acid infusion. These results indicate that the fetus responds to an acute increase in amino acid supply primarily by increasing protein synthesis and accretion, with a smaller but significant increase in amino acid catabolism also. Both phenylalanine hydroxylation and tyrosine oxidation are active in the fetus, and the fetus is able to increase phenylalanine hydroxylation rapidly in response to increased supply.
authors.affiliation: Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
authors.forename: E A
authors.initials: EA
authors.lastname: Liechty
authors.forename: D W
authors.initials: DW
authors.lastname: Boyle
authors.forename: H
authors.initials: H
authors.lastname: Moorehead
authors.forename: L
authors.initials: L
authors.lastname: Auble
authors.forename: S C
authors.initials: SC
authors.lastname: Denne
mesh_terms: D000596:Amino Acids / Q000378:metabolism* / Q000494:pharmacology*; D000818:Animals; D004151:Dipeptides / Q000378:metabolism* / Q000494:pharmacology*; D004338:Drug Combinations; D004573:Electrolytes; D005326:Fetal Proteins / Q000096:biosynthesis*; D005333:Fetus / Q000378:metabolism*; D005947:Glucose; D006900:Hydroxylation; D007262:Infusions, Intravenous; D010084:Oxidation-Reduction; D057947:Parenteral Nutrition Solutions; D010649:Phenylalanine / Q000378:metabolism / Q000493:pharmacokinetics; D012996:Solutions; D014443:Tyrosine / Q000378:metabolism / Q000493:pharmacokinetics
chemical_list: D000596:Amino Acids; D004151:Dipeptides; D004338:Drug Combinations; D004573:Electrolytes; D005326:Fetal Proteins; D057947:Parenteral Nutrition Solutions; D012996:Solutions; C545824:amino-acid, glucose, and electrolyte solution; D014443:Tyrosine; D010649:Phenylalanine; C022013:glycyltyrosine; D005947:Glucose